BCI at the 17th Congress of the European Hematology Association - Amsterdam
 |
The 17th Congress of the European Hematology Association14 - 17 June 2012Amsterdam RAI, Europaplein 22,
|
The European Hematology Association (EHA) annual congress is the premier European hematology meeting that attracts high profile international speakers covering the latest clinical practice and translational research discoveries.
This year the Centre for Haemato-Oncology, led by Professor John Gribben, will be making a major presence with 5 oral presentations and 6 poster presentations. These achievements highlight the international impact of the Centre’s applied cancer immunology research.
Professor Gribben is an invited speaker addressing the optimal clinical management of poor prognosis leukaemia.
Dr Alan Ramsay’s latest work establishing a reversible immune evasion mechanism in cancer has been selected by the scientific committee as one of the six top-scoring abstracts to be presented during the Presidential Symposium.
Dr John Riches, a CR-UK clinical fellow, will present his work characterising a novel phenotype of cytolytic T cells in leukaemia patients that underlines their functional exhaustion.
Dr Paul Greaves will present his novel translational findings in Hodgkin’s lymphoma linking cell-mediated immunity biomarkers to clinical outcome.
Dr Silvia Montoto will present the results of a major European clinical project (LWP-EBMT) on transplant management in follicular lymphoma.
The 6 poster presentations from the Centre are authored by Aine McCarthy (autophagy and follicular lymphoma), Paul Greaves (immunophenoyping T cells in Hodgkin’s lymphoma), Tom Butler (phospho-proteomic mapping in leukaemia), Tim Farren (novel minimal residual disease marker CD160 in leukaemia), Kiran Tawana (clonal mutations in leukaemia) and Floriana Manodoro (high-throughput methylation analysis in leukaemia).
